drugset / Trial / NCT03173625
A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body
RandomizedParallel-groupQuadruple-blindOther
Summary
The main objective of the study is to investigate the safety and tolerability of single ascending doses of AC-076 administered as subcutaneous injection
Timeline
- Start
- 2016-11-29
- Primary completion
- 2017-04-15
- Completion
- 2017-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AC-076 | Unknown | 1 mg | Subcutaneous |
Indications
No indication recorded.